The White House is considering options for maximizing global production and supply of Covid-19 vaccines at the lowest cost, including backing a proposed waiver of intellectual property rights, but no decision has been made, press secretary Jen Psaki said on Tuesday.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3dY9Csd
No comments:
Post a Comment